ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma

(2018) Ruichao Chai et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Endothelial trans-differentiation in glioblastoma recurring after radiotherapy

(2018) Ivana De Pascalis et al.   MODERN PATHOLOGY

Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas

(2018) Rui-Chao Chai et al.   CNS Neuroscience & Therapeutics

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

(2017) Michael Weller et al.   LANCET ONCOLOGY

Prognostic Relevance of Tumor Purity and Interaction with MGMT Methylation in Glioblastoma

(2017) Eva Schulze Heuling et al.   MOLECULAR CANCER RESEARCH

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

Germline variation in ADAMTSL1 is associated with prognosis following breast cancer treatment in young women

(2017) Latha Kadalayil et al.   Nature Communications

Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomas

(2017) Zheng Zhao et al.   Scientific Data

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

CGCG clinical practice guidelines for the management of adult diffuse gliomas

(2016) Tao Jiang et al.   CANCER LETTERS

Telomere profiles and tumor-associated macrophages with different immune signatures affect prognosis in glioblastoma

(2016) Noelyn A Hung et al.   MODERN PATHOLOGY

A founder mutation in ADAMTSL4 causes early-onset bilateral ectopia lentis among Jews of Bukharian origin

(2016) Eyal Reinstein et al.   MOLECULAR GENETICS AND METABOLISM

Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma

(2016) Zheng Wang et al.   OncoImmunology

Biomarkers for glioma immunotherapy: the next generation

(2015) Jennifer S. Sims et al.   JOURNAL OF NEURO-ONCOLOGY

ADAMTS proteins as modulators of microfibril formation and function

(2015) Dirk Hubmacher et al.   MATRIX BIOLOGY

Circulating biomarkers for gliomas

(2015) Manfred Westphal et al.   Nature Reviews Neurology

Human cerebral organoids recapitulate gene expression programs of fetal neocortex development

(2015) J. Gray Camp et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Systematic pan-cancer analysis of tumour purity

(2015) Dvir Aran et al.   Nature Communications

High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2014) R. Stupp et al.   ANNALS OF ONCOLOGY

Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors

(2014) D. A. Wainwright et al.   CLINICAL CANCER RESEARCH

Orchestrating immune check-point blockade for cancer immunotherapy in combinations

(2014) Jose Luis Perez-Gracia et al.   CURRENT OPINION IN IMMUNOLOGY

Hedgehog Pathway Inhibition in Chondrosarcoma Using the Smoothened Inhibitor IPI-926 Directly Inhibits Sarcoma Cell Growth

(2014) V. T. Campbell et al.   MOLECULAR CANCER THERAPEUTICS

Immunotherapy advances for glioblastoma

(2014) D. A. Reardon et al.   NEURO-ONCOLOGY

The epidemiology of glioma in adults: a "state of the science" review

(2014) Q. T. Ostrom et al.   NEURO-ONCOLOGY

Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma

(2014) Anna Sophie Berghoff et al.   NEURO-ONCOLOGY

Ectopia lentis et pupillae in four generations caused by novel mutations in theADAMTSL4gene

(2013) Yassi Sharifi et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Gliomas Promote Immunosuppression through Induction of B7-H1 Expression in Tumor-Associated Macrophages

(2013) O. Bloch et al.   CLINICAL CANCER RESEARCH

Significance of complete 1p/19q co-deletion, IDH1 mutation and MGMT promoter methylation in gliomas: use with caution

(2013) Sandra H E Boots-Sprenger et al.   MODERN PATHOLOGY

Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1

(2010) Roel G.W. Verhaak et al.   CANCER CELL

Role of ADAMTSL4 mutations in FBN1 mutation-negative ectopia lentis patients

(2010) Jose Antonio Aragon-Martin et al.   HUMAN MUTATION

Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology

(2009) L. A.M. Gravendeel et al.   CANCER RESEARCH